To Sleep or Not To Sleep: A Systematic Review of the Literature of Pharmacological Treatments of Insomnia in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: This systematic review assessed current evidence on sleep medication for attention-deficit/hyperactivity disorder (ADHD) patients, to establish appropriate guidance for clinicians faced with prescribing such medications. METHODS: Five articles (based on four pharmacological compounds) out of a total 337 were identified as evidence to guide pharmacological treatment of ADHD-related sleep disorders. Data regarding participant characteristics, measures of ADHD diagnosis, measures of sleep, and outcome data were extracted. RESULTS: Zolpidem and L-theanine both displayed a poor response in reducing sleep latency and increasing total sleep time, however L-theanine did produce an increase in sleep efficiency. Zolpidem produced high levels of side effects, leading to the largest dropout rate of all five studies. Clonidine reduced insomnia; and melatonin also exhibited a positive response, with reduced sleep latency, higher total sleep time, and higher sleep efficiency. CONCLUSIONS: There is a relative paucity of evidence for the pharmacological treatment of ADHD-related sleep disorders; therefore, further research should be conducted to replicate these findings and obtain reliable results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1088 · Cited by 652
Cortese, S., Faraone, S. V., Konofal, E., & Lecendreux, M. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181ac09c9 · Cited by 637
Fishman (2006) · doi:10.1097/01 · Cited by 547
Effect of Melatonin on Sleep, Behavior, and Cognition in ADHD and Chronic Sleep-Onset Insomnia
VAN der HEIJDEN, K. B., SMITS, M. G., VAN SOMEREN, E. J. W., RIDDERINKHOF, K. R., & GUNNING, W. B. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000246055.76167.0d · Cited by 378 · cited 9×
“Methodology was very rigorous in the initial melatonin study by Van der Heijden et al. (2007), ensuring that there was a set time that the melatonin was administered for all participants, excluding any participants who had taken any other medications 4 weeks prior to enrolment, thus guaranteeing…”
InfluentialLong‐term follow‐up of melatonin treatment in children with ADHD and chronic sleep onset insomnia
Hoebert, M., Van Der Heijden, K. B., Van Geijlswijk, I. M., & Smits, M. G. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00681.x · Cited by 220
Effects of Atomoxetine and Methylphenidate on Sleep in Children With ADHD
Sangal, R. B., Owens, J., Allen, A. J., Sutton, V., Schuh, K., & Kelsey, D. (2006) · Sleep · doi:10.1093/sleep/29.12.1573 · Cited by 214
Cohen-Zion, M., & Ancoli-Israel, S. (2004) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2004.06.002 · Cited by 203 · cited 1×
“…(Lyon et al. 2011), in which only males were PHARMACOLOGICAL TREATMENT OF SLEEP DISORDERS IN ADHD studied; however, it is not an unfeasible representation of the general population, as ADHD is three times more common in males than in females (Cohen-Zion and Ancoli-Israel 2004; Lyon et al. 2011).”
Greenhill, L., Puig-Antich, J., Goetz, R., Hanlon, C., & Davies, M. (1983) · Sleep · doi:10.1093/sleep/6.2.91 · Cited by 121 · cited 1×
“…sleep disturbances such as chronic sleep onset insomnia (CSOI) (Corkum et al. 1999), and overall, 48– 73% of children with ADHD have experienced sleep difficulties in childhood (Greenhill et al. 1983; Allen et al. 1992; Sung et al. 2008) compared with * 10% of healthy controls (Allen et al. 1992).”
Melatonin Treatment for Insomnia in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder
Bendz, L. M., & Scates, A. C. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1m365 · Cited by 114 · cited 1×
“There have been two recent reviews on the use of melatonin in treatment of insomnia in ADHD (Bendz and Scates 2010; Miner 2012); however, there have been no previous systematic reviews on the topic of pharmacological interventions in ADHD-related sleep disturbances.”
Clonidine for Sleep Disturbances Associated with Attention-Deficit Hyperactivity Disorder
WILENS, T. E., BIEDERMAN, J., & SPENCER, T. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199403000-00018 · Cited by 101 · cited 5×
“trazodone), a-adrenergic agonists, or exogenous melatonin (Wilens et al. 1994; Prince et al. 1996; Owens et al. 2010).”
InfluentialLecendreux, M., & Cortese, S. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.12.1799 · Cited by 58 · cited 2×
“2011), an alternative epiphenomenon stemming from core ADHD symptoms (Weiss and Salpekar 2010), a psychiatric comorbidity (Lecendreux and Cortese 2007; Tsai and Huang 2010), or a combination of them.”
Effects of Once-Daily Oral and Transdermal Methylphenidate on Sleep Behavior of Children With ADHD
Faraone, S. V., Glatt, S. J., Bukstein, O. G., Lopez, F. A., Arnold, L. E., & Findling, R. L. (2009) · Journal of Attention Disorders · doi:10.1177/1087054708314844 · Cited by 56 · cited 2×
“We can hypothesize that sleep disturbances in ADHD may be either an adverse effect of pharmacological treatment (Sangal et al. 2006; Faraone et al. 2009; Giblin and Strobel 2011; Huang et al. 2011), an alternative epiphenomenon stemming from core ADHD symptoms (Weiss and Salpekar 2010), a psychiatric comorbidity (Lece…”
Effect of Lisdexamfetamine Dimesylate on Sleep in Children With ADHD
Giblin, J. M., & Strobel, A. L. (2011) · Journal of Attention Disorders · doi:10.1177/1087054710371195 · Cited by 38 · cited 2×
“We can hypothesize that sleep disturbances in ADHD may be either an adverse effect of pharmacological treatment (Sangal et al. 2006; Faraone et al. 2009; Giblin and Strobel 2011; Huang et al. 2011), an alternative epiphenomenon stemming from core ADHD symptoms (Weiss and Salpekar 2010), a psychiatric comorbidity (Lece…”
Cited by
Updated European Consensus Statement on diagnosis and treatment of adult ADHD
Kooij, J. J. S., Bijlenga, D., Salerno, L., Jaeschke, R., Bitter, I., Balázs, J., Thome, J., Dom, G., Kasper, S., Nunes Filipe, C., et al. (2019) · European Psychiatry · doi:10.1016/j.eurpsy.2018.11.001 · Cited by 686
“Careful titration of stimulants and psychoeducation around sleep optimization can improve the quality of sleep, possibly due to improved daytime structure, the maintenance of regular physical activity and improved mood [198,309,311].”
BackgroundInsomnia disorder in adolescence: Diagnosis, impact, and treatment
de Zambotti, M., Goldstone, A., Colrain, I. M., & Baker, F. C. (2018) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2017.06.009 · Cited by 393
Sleep disturbances in adolescents with ADHD: A systematic review and framework for future research
Lunsford-Avery, J. R., Krystal, A. D., & Kollins, S. H. (2016) · Clinical Psychology Review · doi:10.1016/j.cpr.2016.10.004 · Cited by 131
Yoneda, Y., Kuramoto, N., & Kawada, K. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104505 · Cited by 39
An L-Glutamine transporter isoform for neurogenesis facilitated by L-Theanine
Yoneda, Y. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2317-6 · Cited by 23
Metadata
- Authors
- Barrett, J. R., Tracy, D. K., & Giaroli, G.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2013-12
- Volume
- 23
- Issue
- 10
- Pages
- 640-647
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2028148414
- Cited by
- 61
- References
- 14
- FWCI
- 0.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.